Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 2:09 AM
Ignite Modification Date: 2025-12-26 @ 12:37 AM
NCT ID: NCT02327260
Description: Adverse events were not assessed because none was anticipated given the focus of the study.
Frequency Threshold: 0
Time Frame: None
Study: NCT02327260
Study Brief: Increasing Adherence to Treatment Recommendations Following a Cardiac Event
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Video + MI for CR This group receives the educational video and an MI session for CR participation. Video + Motivational interview for CR participation: Patients will be shown a 9 minute video that highlights actual CR patients discussing barriers they overcame to participate in CR, and introductions to the CR staff. The brief, phone-based motivational interview will focus on increasing motivation to participate in CR. 0 None 0 0 0 0 View
MI for Medication Adherence This group receives an MI session for taking prescribed cardioprotective medications, Motivational interview for medication adherence: The brief, phone-based motivational interview will focus on increasing motivation to adhere to prescribed cardioprotective medications. 0 None 0 0 0 0 View
Control Group (Standard Care) This group received standard care following a cardiac procedure. 0 None 0 0 0 0 View
Serious Events(If Any):
Other Events(If Any):